First Thoraguard Study Completed at Stanford University Medical Center –

Latest Guidelines to Enhance Patient Recovery after Cardiac Surgery

Strongly Recommend: Maintenance of Chest Tube Patency to Prevent Complications

OMAHA, Neb. – January 21, 2020Centese, Inc. today announced completion of the first clinical study of its Thoraguard® digital drainage system used in cardiac surgery at Stanford University Medical Center. Thoraguard is the first surgical drainage device to provide automated clog clearance without requiring human intervention, and digitally measures and displays hourly drainage volume and trends to facilitate clinical decision-making after cardiac surgery.

“Effective post-surgical drainage is critical to a patient’s wellbeing and recovery, and when chest tubes clog they can put patients at risk,” said Jack Boyd, MD, cardiothoracic surgeon and principal investigator of the study at Stanford University Medical…

Read more…

Leave a Reply